Anirudh Bakam
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Anirudh Bakam has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Sai Krishna Tikka
Department of Psychiatry, All India Institute of Medical Sciences, Bibinagar, Hyderabad, India
3 shared publications- Barikar Chandrappa Malathesh
Dept. of Psychiatry, All India Institute of Medical Sciences (AIIMS), Bibinagar, Hyderabad, Telangana, India
2 shared publications - Sai Krishna Tikka
AIIMS Bibinagar, Hyderabad, Telangana, India
2 shared publications Sai Spoorthy Mamidipalli
Department of Psychiatry, All India Institute of Medical Sciences, Bibinagar, Hyderabad, India
2 shared publicationsSanthini Ajay
All India Institute of Medical Sciences
2 shared publicationsShushank Tej Tekupalli
Department of Psychiatry, All India Institute of Medical Sciences, Bibinagar, Hyderabad, India
2 shared publications
Latest Publications
- 30 June 2026
- Published by Physicians Postgraduate Press, Inc in The Primary Care Companion For CNS Disorders
- Vol. 28 (4)
Fluoxetine-Induced Liver Injury in a Patient With Post-Schizophrenic Depression
- 30 June 2026
- Published by Physicians Postgraduate Press, Inc in The Primary Care Companion For CNS Disorders
- Vol. 28 (4)
Fluoxetine-Induced Liver Injury in a Patient With Post-Schizophrenic Depression
- 25 March 2026
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 229 (5) , 574-575
Adolescent attention-deficit hyperactivity disorder symptoms and adult outcomes: re-look at the threshold of exposure, retrospective labelling and possible social desirability bias in reported outcomes
- 25 March 2026
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 229 (5) , 574-575
Adolescent attention-deficit hyperactivity disorder symptoms and adult outcomes: re-look at the threshold of exposure, retrospective labelling and possible social desirability bias in reported outcomes
- Open Access
- 23 February 2026
- Published by Wolters Kluwer Health in Indian Journal of Psychiatry
- Vol. 68 (2) , 206-207
Comments on “Ketamine’s double-edged sword: Therapeutic benefits and adverse events in adolescent treatment-resistant obsessive compulsive disorder (OCD)—A case series”
- 23 February 2026
- Published by Wolters Kluwer Health in Indian Journal of Psychiatry
- Vol. 68 (2) , 206-207
Open AccessComments on “Ketamine’s double-edged sword: Therapeutic benefits and adverse events in adolescent treatment-resistant obsessive compulsive disorder (OCD)—A case series”
- 3 February 2026
- Published by Physicians Postgraduate Press, Inc in The Primary Care Companion For CNS Disorders
- Vol. 28 (1)
Periodic Catatonia in an Adult With Autism Spectrum Disorder Responding to Lithium
- 3 February 2026
- Published by Physicians Postgraduate Press, Inc in The Primary Care Companion For CNS Disorders
- Vol. 28 (1)
Periodic Catatonia in an Adult With Autism Spectrum Disorder Responding to Lithium
- 13 December 2025
- Published by Elsevier in Psychiatry Research
- Vol. 356, 116906
Comments on “Association between childhood hunger and depression or anxiety in later life: Insights from two case-control studies”
- 13 December 2025
- Published by Elsevier in Psychiatry Research
- Vol. 356, 116906
Comments on “Association between childhood hunger and depression or anxiety in later life: Insights from two case-control studies”
- Open Access
- 5 November 2025
- Published by MDPI AG in Preprints.org
Neuroimaging in Psychiatry: An Overview
Psychiatric diagnoses remain largely reliant on clinical observation and self-report, lacking validated biological markers to ensure reliability and specificity. Neuroimaging has emerged as a critical tool to bridge this gap by enabling in vivo assessment of brain structure, connectivity, and neurochemistry. Structural modalities such as MRI and diffusion tensor imaging (DTI) have illuminated consistent alterations in cortical and white-matter networks across schizophrenia, obsessive-compulsive disorder, bipolar disorder, and major depressive disorder, offering insights into shared and disorder-specific pathophysiology. Functional imaging techniques—including fMRI, PET, and SPECT—have further delineated dysconnectivity in key circuits and neurotransmitter abnormalities, reinforcing a network-based model of mental illness. While neuroimaging currently lacks diagnostic specificity for individual patients, its integration with machine learning, genetics, and multimodal biomarkers holds promise for precision psychiatry. Future directions emphasize large-scale harmonized datasets, multimodal fusion, and AI-assisted analysis to develop clinically meaningful biomarkers that can guide diagnosis, predict treatment response, and inform targeted neuromodulation strategies. Neuroimaging thus represents a transformative frontier linking neuroscience and psychiatric practice.
- 5 November 2025
- Published by MDPI AG in Preprints.org
Open AccessNeuroimaging in Psychiatry: An Overview
Psychiatric diagnoses remain largely reliant on clinical observation and self-report, lacking validated biological markers to ensure reliability and specificity. Neuroimaging has emerged as a critical tool to bridge this gap by enabling in vivo assessment of brain structure, connectivity, and neurochemistry. Structural modalities such as MRI and diffusion tensor imaging (DTI) have illuminated consistent alterations in cortical and white-matter networks across schizophrenia, obsessive-compulsive disorder, bipolar disorder, and major depressive disorder, offering insights into shared and disorder-specific pathophysiology. Functional imaging techniques—including fMRI, PET, and SPECT—have further delineated dysconnectivity in key circuits and neurotransmitter abnormalities, reinforcing a network-based model of mental illness. While neuroimaging currently lacks diagnostic specificity for individual patients, its integration with machine learning, genetics, and multimodal biomarkers holds promise for precision psychiatry. Future directions emphasize large-scale harmonized datasets, multimodal fusion, and AI-assisted analysis to develop clinically meaningful biomarkers that can guide diagnosis, predict treatment response, and inform targeted neuromodulation strategies. Neuroimaging thus represents a transformative frontier linking neuroscience and psychiatric practice.
- Open Access
- 18 August 2025
- Published by MDPI AG in Preprints.org
Recent Advances in the Treatment of OCD
This review synthesizes recent advances in the management of obsessive-compulsive disorder (OCD), a chronic and disabling psychiatric condition in which 40–60% of patients remain symptomatic despite first-line treatments such as selective serotonin reuptake inhibitors (SSRIs) and cognitive-behavioural therapy with exposure and response prevention (ERP). Innovations in psychotherapy include inhibitory learning–based ERP, the Bergen 4-Day Treatment, intensive inpatient CBT, digital and virtual reality–delivered ERP, AI-assisted interventions, and adjunctive modalities such as metacognitive therapy, acceptance and commitment therapy, and danger ideation reduction therapy. Pharmacological progress has been slower, though high-dose SSRIs, venlafaxine, antipsychotic augmentation, glutamatergic modulators, cannabinoids, ketamine, psychedelics, and other investigational agents show promise for treatment-resistant cases. Neuromodulation techniques—particularly deep transcranial magnetic stimulation, accelerated TMS protocols, transcranial direct and alternating current stimulation, and drug-assisted TMS—offer non-invasive augmentation options, while advances in psychosurgery, including refined gamma knife capsulotomy, deep brain stimulation, and emerging adaptive closed-loop DBS, provide hope for the most refractory patients. Future directions emphasize integrative, personalized, and technology-enhanced approaches, leveraging neuroimaging, computational psychiatry, and biomarker-driven treatment selection to improve outcomes in this complex disorder.
- 18 August 2025
- Published by MDPI AG in Preprints.org
Open AccessRecent Advances in the Treatment of OCD
This review synthesizes recent advances in the management of obsessive-compulsive disorder (OCD), a chronic and disabling psychiatric condition in which 40–60% of patients remain symptomatic despite first-line treatments such as selective serotonin reuptake inhibitors (SSRIs) and cognitive-behavioural therapy with exposure and response prevention (ERP). Innovations in psychotherapy include inhibitory learning–based ERP, the Bergen 4-Day Treatment, intensive inpatient CBT, digital and virtual reality–delivered ERP, AI-assisted interventions, and adjunctive modalities such as metacognitive therapy, acceptance and commitment therapy, and danger ideation reduction therapy. Pharmacological progress has been slower, though high-dose SSRIs, venlafaxine, antipsychotic augmentation, glutamatergic modulators, cannabinoids, ketamine, psychedelics, and other investigational agents show promise for treatment-resistant cases. Neuromodulation techniques—particularly deep transcranial magnetic stimulation, accelerated TMS protocols, transcranial direct and alternating current stimulation, and drug-assisted TMS—offer non-invasive augmentation options, while advances in psychosurgery, including refined gamma knife capsulotomy, deep brain stimulation, and emerging adaptive closed-loop DBS, provide hope for the most refractory patients. Future directions emphasize integrative, personalized, and technology-enhanced approaches, leveraging neuroimaging, computational psychiatry, and biomarker-driven treatment selection to improve outcomes in this complex disorder.
- Open Access
- 28 August 2024
- Published by SAGE Publications in Indian Journal of Psychological Medicine
- Vol. 47 (2) , 195-196
A Local Vernacular Variant of the Foreign Accent Syndrome Associated with Wernicke’s Aphasia Masquerading as Dissociative Neurological Symptom Disorder: A Case Report
- 28 August 2024
- Published by SAGE Publications in Indian Journal of Psychological Medicine
- Vol. 47 (2) , 195-196
Open AccessA Local Vernacular Variant of the Foreign Accent Syndrome Associated with Wernicke’s Aphasia Masquerading as Dissociative Neurological Symptom Disorder: A Case Report